Get the Stockscreener App
1.87
2.09%
-0.04
Fortress Biotech Inc stock is traded at $1.87, with a volume of 264.28K.
It is down -2.09% in the last 24 hours and down -23.98% over the past month.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.
See More
Previous Close:
$1.91
Open:
$1.92
24h Volume:
264.28K
Relative Volume:
0.95
Market Cap:
$62.37M
Revenue:
$66.16M
Net Income/Loss:
$128.94M
P/E Ratio:
0.5876
EPS:
3.1823
Net Cash Flow:
$152.08M
1W Performance:
-12.41%
1M Performance:
-23.98%
6M Performance:
-20.43%
1Y Performance:
-31.75%
1-Day Range:
$1.84
$1.925
1-Week Range:
$1.84
$2.134
52-Week Range:
$1.84
$4.53
Fortress Biotech Inc Stock (FBIO) Company Profile
Name
Fortress Biotech Inc
Sector
Industry
Phone
781-652-4500
Address
1111 KANE CONCOURSE, BAY HARBOR ISLANDS, NY
Compare FBIO vs VRTX, MRNA, REGN, ARGX, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
FBIO
Fortress Biotech Inc
|
1.87 | 62.37M | 66.16M | 128.94M | 152.08M | 3.1823 |
VRTX
Vertex Pharmaceuticals Inc
|
499.74 | 126.66B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
218.01 | 87.04B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
790.74 | 81.41B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
819.14 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
369.06 | 41.75B | 5.76B | 514.49M | 1.10B | 4.4813 |
Fortress Biotech Inc Stock (FBIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-15-24 | Resumed | ROTH MKM | Buy |
| Aug-04-22 | Initiated | Ladenburg Thalmann | Buy |
| Oct-02-20 | Initiated | The Benchmark Company | Buy |
| Dec-18-19 | Initiated | B. Riley FBR | Buy |
| Feb-28-18 | Initiated | B. Riley FBR, Inc. | Buy |
| Jul-11-17 | Initiated | Rodman & Renshaw | Buy |
| Mar-22-17 | Initiated | JMP Securities | Mkt Outperform |
| Oct-03-16 | Initiated | ROTH Capital | Buy |
View All
Fortress Biotech Inc Stock (FBIO) Latest News
Fortress Biotech repays USD 15 million debt: what it means for Fortress Biotech stock - ad-hoc-news.de
Fortress Biotech stock gains as USD 15.0 million debt is repaid - ad-hoc-news.de
Fortress Biotech stock fell 1.93 percent on October 2 - ad-hoc-news.de
Fortress Biotech Stock Price Forecast. Should You Buy FBIO? - StockInvest.us
Fortress Biotech Inc (FBIO-Q) Stock Price and News - The Globe and Mail
Fortress Biotech Inc 9.375% Series A Cumulativ (FBIOP-Q) Stock Price and News - The Globe and Mail
Fortress Biotech (FBIO) Slips 3.27% to $2.07 as Shares Drift Toward Lower SupportBearish Sentiment - siam.in
Form 8K Fortress Biotech Inc For: 1 October By Investing.com - Investing.com Nigeria
Fortress Biotech repays $15 million Oaktree credit facility in full - Investing.com
Fortress Biotech repays $15 million Oaktree credit facility in full By Investing.com - Investing.com Nigeria
Form 8K Fortress Biotech Inc For: 1 October By Investing.com - Investing.com Canada
Form 8K Fortress Biotech Inc For: 1 October By Investing.com - Investing.com UK
Fortress Biotech repaid $15.0M and terminated Oaktree secured credit facility - TradingView
Through its employee stock purchase plan, Fortress Biotech (FBIO) CFO David Jin acquires 1,190 shares. - stocktitan.net
Fortress Biotech, Inc. Repays Remaining $15 Million Outstanding Principal Under Oaktree Agreement - www.marketscreener.com
CNB0 Bond Profile: Coupon and Redemption - TradingView
Precision Trading with Fortress Biotech Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock (FBIOP) Risk Zones - Stock Traders Daily
Latest Fortress Biotech, Inc.9.375% Series A Cumulative Redeemable Perpetual Preferred Stock news - Securities.io
Precision Trading with Fortress Biotech Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock (FBIOP) Risk Zones - Stock Traders Daily
Fortress Biotech's business presentation goes online Sept. 11 - Stock Titan
Fortress Biotech to Present at the H.C. Wainwright 28th Annual Global Investment Conference - Yahoo Finance
Fortress Biotech to Present at the H.C. Wainwright 28th Annual Global Investment Conference - GlobeNewswire
Fortress Biotech to Present at the H.C. Wainwright 28th Annual Global Investment Conference - Moomoo
Best Cheap Stocks Under $10 with High Return Potential (September 2026) - Investing.com
Fortress Biotech (FBIO) Rises to $2.73 as Buyers Defend Key Support ZoneWide Range Bar - dars.gov.et
Fortress Biotech (FBIO) Rises to $2.73 as Buyers Defend Key Support ZoneBlue Chip Entry Points - siam.in
Fortress Biotech (FBIO) Rises to $2.73 as Buyers Defend Key Support ZoneRunaway Gap - vinanet.vn
Integrated Core Strategies (US) LLC Discloses 5.3% Stake in Fortress Biotech (NASDAQ: FBIO) via 13G Filing - Kalkine Media
Passive stake disclosed in Fortress Biotech (NASDAQ: FBIO) by Millennium group - Stock Titan
(FBIOP) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Fortress Biotech Inc. (FBIO) Shareholding Pattern – Promoters, FIIs & DIIs - valueresearchonline.com
A. G. P. Maintains Fortress Biotech(FBIO.US) With Buy Rating, Maintains Target Price $5 - Moomoo
FBIO | Fortress Biotech, Inc. FinancialsRevenue Breakdown - Quiver Quantitative
Fortress Biotech (FBIO) Q2 2026 Earnings Call Transcript - AOL.ca
ETFs Investing in Fortress Biotech, Inc. Stocks - TradingView
Fortress Biotech (FBIO) Slips 1.68% to $2.93 as Small-Cap Biotech Faces PressureBollinger Squeeze - vinanet.vn
Fortress Biotech (NASDAQ:FBIO) Lowered to Hold Rating by Wall Street Zen - MarketBeat
Fortress Biotech (FBIO) Pulls Back 3% as Shares Approach Key $2.75 SupportFear Greed Index - vinanet.vn
Fortress Biotech (FBIO) Pulls Back 3% as Shares Approach Key $2.75 SupportATR Stop - dars.gov.et
Fortress Biotech, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Fortress Biotech earnings beat by $0.11, revenue fell short of estimates - Investing.com Canada
Fortress Biotech (NASDAQ:FBIO) Posts Earnings Results, Beats Estimates By $0.12 EPS - MarketBeat
Fortress Biotech: Q2 Earnings Snapshot - marketscreener.com
Fortress Biotech: Q2 Earnings Snapshot - AOL.com
Fortress Biotech: Q2 Earnings Snapshot - KTVB
Fortress Biotech Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Fortress Biotech 2026: Revenue $17.84M, Net income ($2.48M), EPS ($0.08) — 10-Q Summary - TradingView
Fortress Biotech (NASDAQ: FBIO) gains $158.9M from voucher sale and boosts cash - Stock Titan
Fortress Biotech Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights - GlobeNewswire
Fortress Biotech Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights - Yahoo Finance
Fortress Biotech Inc Stock (FBIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):